Podcasts about Lesion

En este episodio entrevistamos a Bernat de las Heras, investigador en neurorehabilitación y experto en neuroplasticidad post-ictus. Desde su formación inicial en Ciencias del Deporte hasta su doctorado en la Universidad McGill, Bernat ha explorado cómo el ejercicio cardiovascular —en especial el aeróbico y HIIT— puede modular la neuroplasticidad cerebral tras un ictus. Bernat nos explica los beneficios y limitaciones del entrenamiento interválico de alta intensidad, su percepción por parte de los pacientes, y cómo combinarlo de forma efectiva con otras estrategias terapéuticas. Hablamos también de aprendizaje y localización de la lesión. Una conversación profunda y práctica para entender los límites actuales de la evidencia, y al mismo tiempo, abrir nuevas vías para la rehabilitación neurológica individualizada. Referencias del episodio: 1) Ploughman, M., Attwood, Z., White, N., Doré, J. J., & Corbett, D. (2007). Endurance exercise facilitates relearning of forelimb motor skill after focal ischemia. The European journal of neuroscience, 25(11), 3453–3460. https://doi.org/10.1111/j.1460-9568.2007.05591.x (https://pubmed.ncbi.nlm.nih.gov/17553014/). 2) Jeffers, M. S., & Corbett, D. (2018). Synergistic Effects of Enriched Environment and Task-Specific Reach Training on Poststroke Recovery of Motor Function. Stroke, 49(6), 1496–1503. https://doi.org/10.1161/STROKEAHA.118.020814 (https://pubmed.ncbi.nlm.nih.gov/29752347/). 3) De Las Heras, B., Rodrigues, L., Cristini, J., Moncion, K., Ploughman, M., Tang, A., Fung, J., & Roig, M. (2024). Measuring Neuroplasticity in Response to Cardiovascular Exercise in People With Stroke: A Critical Perspective. Neurorehabilitation and neural repair, 38(4), 303–321. https://doi.org/10.1177/15459683231223513 (https://pubmed.ncbi.nlm.nih.gov/38291890/). 4) Roig, M., & de Las Heras, B. (2018). Acute cardiovascular exercise does not enhance locomotor learning in people with stroke. The Journal of physiology, 596(10), 1785–1786. https://doi.org/10.1113/JP276172 (https://pubmed.ncbi.nlm.nih.gov/29603752/). 5) Rodrigues, L., Moncion, K., Eng, J. J., Noguchi, K. S., Wiley, E., de Las Heras, B., Sweet, S. N., Fung, J., MacKay-Lyons, M., Nelson, A. J., Medeiros, D., Crozier, J., Thiel, A., Tang, A., & Roig, M. (2022). Intensity matters: protocol for a randomized controlled trial exercise intervention for individuals with chronic stroke. Trials, 23(1), 442. https://doi.org/10.1186/s13063-022-06359-w (https://pubmed.ncbi.nlm.nih.gov/35610659/). 6) Cristini, J., Kraft, V. S., De Las Heras, B., Rodrigues, L., Parwanta, Z., Hermsdörfer, J., Steib, S., & Roig, M. (2023). Differential effects of acute cardiovascular exercise on explicit and implicit motor memory: The moderating effects of fitness level. Neurobiology of learning and memory, 205, 107846. https://doi.org/10.1016/j.nlm.2023.107846 (https://pubmed.ncbi.nlm.nih.gov/37865261/). 7) Moncion, K., Rodrigues, L., De Las Heras, B., Noguchi, K. S., Wiley, E., Eng, J. J., MacKay-Lyons, M., Sweet, S. N., Thiel, A., Fung, J., Stratford, P., Richardson, J. A., MacDonald, M. J., Roig, M., & Tang, A. (2024). Cardiorespiratory Fitness Benefits of High-Intensity Interval Training After Stroke: A Randomized Controlled Trial. Stroke, 55(9), 2202–2211. https://doi.org/10.1161/STROKEAHA.124.046564 (https://pubmed.ncbi.nlm.nih.gov/39113181/). 8) De las Heras, B., Rodrigues, L., Cristini, J., Moncion, K., Dancause, N., Thiel, A., Edwards, J. D., Eng, J. J., Tang, A., & Roig, M. (2024). Lesion location changes the association between brain excitability and motor skill acquisition post-stroke. medRxiv. https://doi.org/10.1101/2024.07.30.24311146 (https://www.medrxiv.org/content/10.1101/2024.07.30.24311146v1.article-info). 9) Rodrigues, L., Moncion, K., Angelopoulos, S. A., Heras, B. L., Sweet, S., Eng, J. J., Fung, J., MacKay-Lyons, M., Tang, A., & Roig, M. (2025). Psychosocial Responses to a Cardiovascular Exercise Randomized Controlled Trial: Does Intensity Matter for Individuals Post-stroke?. Archives of physical medicine and rehabilitation, S0003-9993(25)00498-8. Advance online publication. https://doi.org/10.1016/j.apmr.2025.01.468 (https://pubmed.ncbi.nlm.nih.gov/39894292/). 10) de Las Heras, B., Rodrigues, L., Cristini, J., Weiss, M., Prats-Puig, A., & Roig, M. (2022). Does the Brain-Derived Neurotrophic Factor Val66Met Polymorphism Modulate the Effects of Physical Activity and Exercise on Cognition?. The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry, 28(1), 69–86. https://doi.org/10.1177/1073858420975712 (https://pubmed.ncbi.nlm.nih.gov/33300425/). 11) MacKay-Lyons, M., Billinger, S. A., Eng, J. J., Dromerick, A., Giacomantonio, N., Hafer-Macko, C., Macko, R., Nguyen, E., Prior, P., Suskin, N., Tang, A., Thornton, M., & Unsworth, K. (2020). Aerobic Exercise Recommendations to Optimize Best Practices in Care After Stroke: AEROBICS 2019 Update. Physical therapy, 100(1), 149–156. https://doi.org/10.1093/ptj/pzz153 (https://pubmed.ncbi.nlm.nih.gov/31596465/).

In this episode, we answer whether you can prevent a cyclops lesion from happening in ACL rehab. We give some background on a cyclops lesion, theories behind it, factors we see contributing to one forming, answering the question, and creating a game plan for it.Ways we can connect:My IG: www.instagram.com/ravipatel.dptOur website: www.theaclathlete.comEmail: ravi@theaclathlete.com_________________Submit a topic or a question you'd like me to answer.Check out our website and tons of free ACL resourcesSign up for The ACL Athlete - VALUE Newsletter (an exclusive newsletter packed with value - ACL advice, go-to exercises, ACL research reviews, athlete wins, frameworks we use, mindset coaching, blog articles, podcast episodes, and pre-launch access to some exciting projects we have lined up)1-on-1 Remote ACL Coaching - A clear plan. Structured ACL program. Based on your goals. Expert guidance and support with every step. Objective testing from anywhere in the world.Send me a text and share anything about the podcast - an episode that hit home or how the podcast has helped you in your journey.

Acompañanos en estas 2 parte de las Perlas de Entre Nefros del Congreso Internacional de Nefrologia 2024, el cual nos sirve como resumen de lo acontecido en este 2024 contamos con la Gran Participacion de Juan Carlos Ramirez Lider de Opinion y entusiaste de la enseñanza en nuestro país, asi como el Dr Alberto Ortiz en puntos importantes de trasplante renal, el Dr Fonseca quien es el impulsor de NEfrogeriatria en el país, una Gran Mancuerna de expertos Internacionales en Glomerulopatias el Dr Mejia Vilet y Dr Rovin, en Lesion renal aguda Dra Lilia y Dr Neyra, en Nefro Pediatria Dra Ferris y Dra Madeiros, participación de un apreciado profesor Dr Sergio Herndez Ordoñez con las perlas de Dialisis y Hemodialisis, el Dr Rolando Claure con Lesion renal aguada y el Dr Salvador Lopez Gil con puntos clave de Hemodiafiltracion, sin duda 2 capitulos que abarcan los avances mas importantes de la nefrología este 2024, esperemos los Disfuentes Y Todo el Equipo de Entre Nefros les deseamos un Exitoso, Retador, Estimulante y Satisfactorio 2025, Nos Escuchamos pronto… Feliz Año 2025…. 0811/107

INFINITY-SWEDEHEART Complex PCI: 1-Year Landmark 6–12 Month Clinical Outcomes Among Patients with Complex Lesion Subsets Treated with DynamX Bioadaptor Compared to a Contemporary Drug Eluting Stent

N Engl J Med 2010;362:1663-74.Background: The RAVEL and TAXUS-IV trials compared the sirolimus- and paclitaxel-eluting 2nd generation stents to 1st generation bare metal stents. Both trials reported improvements in surrogate endpoints - “in-stent luminal loss” was the primary endpoint of RAVEL and “ischemia-driven target-vessel revascularization” was the primary endpoint of TAXUS-IV. Neither trial showed differences in hard endpoints like death or MI but were not powered for such events.The observation that restenosis still occurred with 2nd generation stents drove interest in developing newer stent technology with improved bioavailability and drug delivery. The 3rd generation everolimus-eluting stent was felt to represent such a development but like its predecessors had only been tested in experiments using surrogate endpoints that were not driven by clinical symptoms. Thus, the SPIRIT IV trial sought to test the hypothesis that 3rd generation everolimus-eluting stents would reduce patient-driven clinical outcomes compared 2nd generation paclitaxel-eluting stents. Furthermore, it was designed to be large enough to provide data on important subgroups, especially patients with diabetes.Patients: Limited details are provided about inclusion and exclusion criteria in the main manuscript and readers are directed to a previous publication and supplemental appendix. Lesion characteristics had to be less than 28 mm in length with a reference-vessel diameter between 2.5 to 3.75 mm. Patients were excluded if they had features making them complex from either a clinical or angiographic standpoint. *Note to learners: Be especially skeptical of trials that do not include at least an abridged version of important inclusion and exclusion criteria in the main publication manuscript. This often indicates that the criteria are complex and that patients are highly selected, which limits the generalizability of the findings to routine practice. Baseline characteristics: The average age of patients was 63 years and 68% were men. Approximately 32% of patients had diabetes with about one quarter being insulin-dependent. Over 20%of patients smoked and a similar percentage had a previous heart attack.Three quarters of patients had 1 target lesion, 22% had 2 target lesions and 3% had 3 and 11% of patients had 1 or more complex lesions. The average lesion length was 15 mm, reference-vessel diameter was 2.75 mm, minimal luminal diameter was 0.75 mm, and average % stenosis was 72%.Procedures: Patients were randomized in a 2:1 ratio to receive an everolimus- or paclitaxel-eluting stent. They were stratified based on having diabetes or not, whether they had a single or complex lesion, and study site. Operators were not blind to the stent being used. At least 300 mg of aspirin was administered before catheterization and at least 300 mg of clopidogrel was recommended before the procedure and was required within 1 hour after stent implantation. Patients took at least 80 mg of aspirin daily for an indefinite period and 75 mg of clopidogrel for at least 12 months. Clinical follow-up visits were scheduled at 30, 180, 270, and 365 days and yearly through 5 years.Endpoints: The primary end point was ischemia-driven target lesion failure at 1 year defined by the composite of cardiac death, target-vessel myocardial infarction, or ischemia-driven target-lesion revascularization. As was the case in the TAXUS-IV trial, “ischemia-driven” did not necessarily mean “symptom-driven”. Two major secondary endpoints were also prespecified which included ischemia-driven target-lesion revascularization and the composite of death or target-vessel MI.The trial was powered for sequential testing of noninferiority and superiority for both the primary and 2 major secondary endpoints. The criteria for noninferiority would be met if the upper limit of the 97.5% confidence interval was not more than 3.1%. This was based on an assumed 1 year target-lesion failure rate of 8.2% for both groups. The trial had 90% power to show non-inferiority. Superiority testing was prespecified if the criterion for noninferiority was met. It was estimated that 3690 patients would have 90% power to detect a 2.9% absolute reduction in the primary end point, at a two-sided alpha of 0.05. The trial also had 90% power to test noninferiority for ischemia-driven target-lesion revascularization and the composite of cardiac death or target-vessel MI at a 2.1% margin. It had 90% and 91% power to test for superiority of these endpoints if noninferiority was met.*Note to learners: The statistical analysis plan for this trial demonstrates 2 important concepts in hypothesis testing. First, trials can be powered in a prespecified manner for non-inferiority and superiority testing. Second, trials can be powered for prespecified hypothesis testing of more than just a single endpoint.Results: Patients were enrolled over a 2 year period from 66 U.S. sites. There were a total of 3,687 patients included in the final analysis with 2,458 in the everolimus-eluting stent group and 1,229 in the paclitaxel-eluting stent group. There were some significant differences for patients receiving everolimus-eluting stents that included the number of stents per lesion, total stent length per lesion, the ratio of stent length to lesion length and the maximum pressure used.At 1 year, everolimus-eluting stents met non-inferiority for the primary and major secondary endpoints and met superiority for 2 of 3. Everolimus-eluting stents reduced the primary endpoint of target-lesion failure (4.2% vs 6.8%; RR 0.62; 95% CI 0.46 to 0.82) and the major secondary endpoint of ischemia-driven target lesion revascularization (2.5 vs 4.6%; RR 0.55; 95% CI 0.38 to 0.78) but not the other major secondary endpoint of cardiac death or target-vessel MI (2.2% vs 3.2%; RR 0.69; 95% CI 0.46 to 1.04). Differences in target-lesion failure were driven by statistically significant reductions in target-lesion revascularization (2.5% vs 4.6%) as well as MI (1.9% vs 3.1%) but not all-cause (1.0% vs 1.3%) or cardiac death (0.4% vs 0.4%). Stent thrombosis was also significantly reduced but rates were very low in both groups and the trial was not powered for this endpoint.Interestingly, subgroup analysis of the primary endpoint revealed a statistically significant interaction for treatment efficacy in patients with diabetes such that diabetics did not appear to benefit from everolimus-eluting stents (6.4% vs 6.9%) compared to non-diabetics (3.3% vs 6.7%; p for interaction = 0.02).Conclusions: In patients with stable CAD who underwent generally non-complex PCI procedures, 3rd generation everolimus-eluting stents compared to 2nd generation paclitaxel-eluting stents reduced a composite endpoint of ischemia-driven target-lesion failure by 38% with a number needed to treat of approximately 40 patients. This was associated with statistically significant reductions in nonfatal MI with a NNT of approximately 100 patients and ischemia-driven target lesion revascularization with a NNT of approximately 50 patients. Everolimus-eluting stents did not reduce death.There was an interaction noted for diabetic patients who did not appear to significantly benefit from everolimus-eluting stents. Notably, diabetics exhibited more severe angiographic disease with a higher prevalence of multivessel disease, diffuse plaque burden, and a greater likelihood of left main coronary artery involvement. This subgroup finding along with the highly selected nature of the study cohort reduces our confidence that the 3rd generation everolimus-eluting stent confers significant advantages over 2nd generation stents for many patients who receive them in clinical practice.One final consideration is that the trial was single blinded and operators were aware of stent type which could have biased their performance and the study results.Cardiology Trial's Substack is a reader-supported publication. To receive new posts and support our work, consider becoming a free or paid subscriber. Get full access to Cardiology Trial's Substack at cardiologytrials.substack.com/subscribe

On this episode we cover a wide range of topics. Hatch kicks off the pod discussing the latest viral acts on social media. Gucci Third Leg fucks up the Only Fans game?! Hatch goes behind the curtain to express the importance of getting tested and practicing safe sex?! The final boss of fuck niggas speaks up and Hatch loses his mind?! Another cop kills a person of color but this time Hatch backs the cop?! Big Meech gets released from prison but the streets calling him a rat… Hatch claims it doesn't matter?! Hatch discusses the pettiest thing he has ever done to his ex?! NBA season is back! Hatch discusses opening night and whether Kawhi Leonard should be forced to retire?! & much much more!Song of the week : Starlito - Live From The KitchenX : OGHatch_FaceBook : OG HatchFaceBook Group Page: Friends of the Show The Thin Line Between Genius & InsanityYouTube: OGHatcchTik Tok : OGHatchTVIG: OGHatch_Rumble : OGHatchThreads :OGHatch_

En este episodio de Voces del Deporte hablamos sobre la lesión de James Rodriguez y sobre el dominio de los grupos económicos estadounidenses en el fútbol europeo.

La final de la Supercopa de Europa la desgranamos con Álvaro Benito y con el resto del Sanedrín. Además, hablamos de la actualidad culé y del Atlético de Madrid, además conocemos las novedades arbitrales de cara a la próxima temporada con Iturralde González y terminamos con el repaso del mercado.

In this episode, we review the high-yield topic of⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SLAP Lesion⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Shoulder & Elbow section. Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Orthobullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on Social Media: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Twitter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube --- Send in a voice message: https://podcasters.spotify.com/pod/show/orthobullets/message

This episode of The Second Degree podcast features an inspiring interview with Meghan Jaskinia, a woman who has overcome significant health challenges and embraced a journey towards wellness and happiness. Meghan shares her journey, starting with a spinal cord lesion that led to the loss of motor function in her left hand. Despite facing uncertainty and receiving alarming diagnoses like multiple sclerosis (MS) or cancer, Meghan took control of her health through nutrition and lifestyle changes. She adopted a vegan, gluten-free, and dairy-free diet, leading to the reversal of her symptoms.The conversation delves into Meghan's emotional rollercoaster during her health crisis, including the fear of not being able to have children. However, Meghan defied expectations and became a mother, embracing unexpected joys amidst her challenges. She emphasizes the crucial role of her supportive partner and her determination to maintain a positive mindset.After experiencing postpartum depression and navigating the complexities of motherhood, Meghan found renewed purpose in helping others on their wellness journeys. She developed a conscious living approach, focusing on small, realistic steps towards health and happiness. By prioritizing self-care and empowering women to prioritize their needs, Meghan aims to make a positive impact and create a community of resilience and support.What You'll Learn:Meet Meghan Jaskinia: Emily Merrell introduces Meghan, a remarkable woman who has triumphed over health challenges and embraced a journey towards wellness and happiness.From Health Crisis to Healing: Meghan shares her experience of facing a spinal cord lesion and the loss of motor function in her hand. Despite daunting diagnoses, she took control of her health through nutrition and lifestyle changes, leading to the reversal of her symptoms.Navigating Motherhood: Despite initial concerns about her health impacting her ability to have children, Meghan defied expectations and became a mother. She reflects on the unexpected joys and challenges of motherhood, emphasizing the importance of support and maintaining a positive mindset.Overcoming Postpartum Depression: Meghan opens up about her struggle with postpartum depression and the journey to rediscover happiness and purpose amidst the complexities of motherhood.The Conscious Living Approach: Meghan discusses her conscious living approach, focusing on small, realistic steps towards health and happiness. She emphasizes the importance of self-care and empowering women to prioritize their well-being.Inspiration and Empowerment: Through Meghan's story, listeners are inspired to embrace resilience, self-discovery, and the pursuit of a fulfilling life. Her journey serves as a beacon of hope for anyone facing adversity and seeking to live their best life.To learn more about Meghan Jaskinia, visit her websiteHealthy and Happy with Ease and follow on instagram at healthyandhappywitheaseSign up for The Second Degree Membership! By becoming a member, we're getting more intimate than ever! Get the Membership now! Check our past episodes of The Second Degree podcast! Remember to follow us on Instagram

Interview with Albert S. Chiou, MD, MBA, author of Single-Lesion Skin Cancer Risk Stratification Triage Pathway. Hosted by Adewole Adamson, MD, MPP. Related Content: Single-Lesion Skin Cancer Risk Stratification Triage Pathway

Interview with Albert S. Chiou, MD, MBA, author of Single-Lesion Skin Cancer Risk Stratification Triage Pathway. Hosted by Adewole Adamson, MD, MPP. Related Content: Single-Lesion Skin Cancer Risk Stratification Triage Pathway

Los Dodgers lideran el Oeste de la Liga Nacional en este show hablamos sobre su desempeño con entrevistas con Mookie Betts, Teoscar Hernandez y José Vizcaino. Explicamos la lesión de Ronald Acuña Jr y otras cositas más en Baseball Ahora. --- Support this podcast: https://podcasters.spotify.com/pod/show/baseballahora/support

Todos hemos experimentado algún tipo de dolor durante nuestra vida. A veces leve, a veces insoportable, en ocasiones físico y en otros momentos emocional. Posiblemente darías lo que fuera por no sentir dolor, ¿pero alguna vez te has preguntado por qué o para qué sentimos dolor? ¿Es realmente algo que queremos evitar a toda costa? Hoy, en el episodio 57, nos acompaña el Dr. Luis Sierra Suárez, quien con su gran conocimiento y sensibilidad nos invita a cambiar nuestra relación con el dolor, a mirarlo desde otra perspectiva, a no verlo como un enemigo que viene a molestarnos, si no como un amigo y aliado que viene a darnos un importante mensaje. Nos detalla los diferentes tipos de dolor que podemos experimentar y nos explica de manera sencilla los complejos y maravillosos mecanismos que nuestro cuerpo utiliza para comunicarnos sobre algún problema que hay que atender. Nos habla sobre los daños que puede causar el enfoque convencional de querer suprimir el dolor sin querer entender la raíz del problema y de algunas de las causas más comunes e insospechadas de muchos de los dolores que experimentamos día a día. Nos comparte varias estrategias para manejar el dolor y entender su causa y, finalmente, con una hermosa reflexión nos exhorta a recordar que nuestro cuerpo es perfecto y que la biología no se equivoca. Luis es natural de México.  Hizo su carrera como Médico Cirujano en la Facultad de Medicina de la Universidad Nacional Autónoma de México (UNAM). Es Cirujano Ortopedista y Traumatólogo, con súper-especialidades en Artroscopia, Lesiones del Deporte y Cirugía de las Articulaciones, complementando su adiestramiento en el Hospital New England Baptist en Boston, Massachusetts.  Fue deportista de alto rendimiento y participó en campeonatos panamericanos, mundiales y pre-Olímpicos y, posteriormente, fue uno de los Médicos de la Delegación Mexicana de los Juegos Olímpicos de Beijing, China.  Actualmente se desarrolla como asesor ortopédico del equipo de fútbol de primera división " Club América" y es profesor adjunto del diplomado de Cirugía Articular del Instituto Nacional de Rehabilitación así como participante activo en múltiples proyectos de investigación. Queremos recordarte que además de este programa en español, la fundación también cuenta con el podcast en inglés “Wise Traditions”. Lo puedes escuchar en Apple, Spotify o en la página web de la fundación westonaprice.org. Nosotros somos Alberto Medina y Anette Ruiz, coanfitriones y productores de “Tradiciones Sabias”, el podcast en español de la Fundación Weston A. Price. Su información de contacto:  Instagram: luis_sierra_suarez_nirvesh  Página web: ortopediadeportiva.com.mx YouTube: Luis Sierra Suárez https://www.youtube.com/channel/UCIELZw3aI8vGqbKFQZGsi6A  Preguntas, comentarios, sugerencias: tradicionessabias@gmail.com   Recursos en español de la Fundación Weston A. Price:  Página web WAPF en Español - https://www.westonaprice.org/espanol/ Cuenta de Instagram - westonaprice_espanol Guía alimentación altamente nutritiva, saludable y placentera - 11 principios dietéticos Paquete de Materiales GRATIS: -https://secure.westonaprice.org/CVWEB_WESTON/cgi-bin/memberdll.dll/openpage?wrp=customer_new_infopak.htm    Folleto "La Leche Real", de Sally Fallon: - https://www.westonaprice.org/wp-content/uploads/La-leche-real.pdf   Música de Pixabay:  Sound Gallery y SOFRA

BUFFALO, NY- May 8, 2024 – A new research paper was published in Oncotarget's Volume 15 on May 7, 2024, entitled, “Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GAN.” The sequential PET/CT studies oncology patients can undergo during their treatment follow-up course is limited by radiation dosage. In this new study, researchers Kevin C. Ma, Esther Mena, Liza Lindenberg, Nathan S. Lay, Phillip Eclarinal, Deborah E. Citrin, Peter A. Pinto, Bradford J. Wood, William L. Dahut, James L. Gulley, Ravi A. Madan, Peter L. Choyke, Ismail Baris Turkbey, and Stephanie A. Harmon from the National Institutes of Health's National Cancer Institute proposed an artificial intelligence (AI) tool to produce attenuation-corrected PET (AC-PET) images from non-attenuation-corrected PET (NAC-PET) images to reduce need for low-dose CT scans. “AI-generated PET images has clinical potential for reducing the need for CT scans for attenuation correction while preserving quantitative markers and image quality in prostate cancer patients.” Methods: A deep learning algorithm based on 2D Pix-2-Pix generative adversarial network (GAN) architecture was developed from paired AC-PET and NAC-PET images. 18F-DCFPyL PSMA (prostate-specific membrane antigen) PET-CT studies from 302 prostate cancer patients, split into training, validation, and testing cohorts (n = 183, 60, 59, respectively). Models were trained with two normalization strategies: Standard Uptake Value (SUV)-based and SUV-Nyul-based. Scan-level performance was evaluated by normalized mean square error (NMSE), mean absolute error (MAE), structural similarity index (SSIM), and peak signal-to-noise ratio (PSNR). Lesion-level analysis was performed in regions-of-interest prospectively from nuclear medicine physicians. SUV metrics were evaluated using intraclass correlation coefficient (ICC), repeatability coefficient (RC), and linear mixed-effects modeling. Results: Median NMSE, MAE, SSIM, and PSNR were 13.26%, 3.59%, 0.891, and 26.82, respectively, in the independent test cohort. ICC for SUVmax and SUVmean were 0.88 and 0.89, which indicated a high correlation between original and AI-generated quantitative imaging markers. Lesion location, density (Hounsfield units), and lesion uptake were all shown to impact relative error in generated SUV metrics (all p < 0.05). “The Pix-2-Pix GAN model for generating AC-PET demonstrates SUV metrics that highly correlate with original images. AI-generated PET images show clinical potential for reducing the need for CT scans for attenuation correction while preserving quantitative markers and image quality.” DOI - https://doi.org/10.18632/oncotarget.28583 Correspondence to - Stephanie A. Harmon - stephanie.harmon@nih.gov Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28583 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

Maddy, Jack, and Sharmin share their approach to focal splenic lesions and splenic infarcts as they discuss a case presented by Youssef.   Frameworks Discussed in Case: Focal Splenic Lesion Splenic Infarct Splenic Infarct vs Abscess   To join us live on Virtual Morning Report (VMR), sign up HERE.  Download CPSolvers App here RLRCPSOLVERS

On this episode of the BackTable MSK podcast, co-hosts Dr. Chris Beck and Dr. Aaron Fritts review the basics of bone lesion biopsy, including patient selection, imaging modalities, and procedural steps. They begin with summarizing indications for bone lesions, which are most common in the setting of metastatic disease. Patients usually get referred for biopsy when a bone lesion is caught on CT imaging of the chest, abdomen, and pelvis. The doctors emphasize that imaging multiple areas is needed to find the most easily accessible lesion, which is sometimes located within a solid organ, rather than within bone. While PET imaging can be useful for confirmation of sclerotic bone lesions, patients usually cannot receive PET scans without an established cancer diagnosis. Dr. Beck highlights the fact that lytic lesions with soft tissue components are technically easier to access than sclerotic lesions and result in higher yield. He occasionally uses a soft tissue biopsy needle for these lesions. For sclerotic lesions, he prefers the OnControl or Stryker bone biopsy coaxial systems. With the coaxial system, it can be hard to adjust the biopsy tract after you have already started drilling, but he recommends obtaining multiple cores at different angles of approach. He also advises listeners to choose the shortest needle possible, since this makes it easier to control and image the needle within the lesion.The doctors also discuss biopsy of tricky locations. Sternal lesions carry the risk of lung injury and pneumothorax, so when faced with these, Dr. Beck picks an oblique tract that has a longer trajectory. For lesions located in proximal extremities, he secures the limb to minimize movement. Next, disc biopsies are discussed. Patients usually present with discitis osteomyelitis from prior back surgery, IV drug use, or idiopathic causes. It is important to distinguish between infection of the disc space versus chronic degenerative disc disease, which can be identified by comparison with prior imaging and lab workup. For the lumbar spine disc biopsy, fluoroscopy is Dr. Beck's preferred imaging modality, and he reviews imaging landmarks. Dr. Fritts usually biopsies both bone and disc. Finally, they discuss post-procedural complications to watch for, such as chest x-rays in checking for lung injury and neurological exams to assess for new deficits. --- CHECK OUT OUR SPONSOR Stryker Interventional Spine https://www.strykerivs.com --- SHOW NOTES 00:00 - Introduction 03:12 - Referrals and Imaging Techniques for Bone Lesion Biopsy 07:09 - Procedural Steps of Bone Lesion Biopsy 12:32 - Choosing Biopsy Tools 23:22 - Approach to Tricky Biopsy Locations 28:19 - Workup and Indications for Disc Biopsy 32:08 - Fluoroscopy vs. CT for Disc Biopsy 40:15 - Handling Biopsy Samples 48:03 - Post-Procedure Care and Complications --- RESOURCES Arrow OnControl Powered Bone Biopsy System: https://irc.teleflex.com/oncontrolsystem/ Stryker Bone Biopsy Coaxial System: https://www.stryker.com/us/en/interventional-spine/products/bone-biopsy.html BD Trek Powered Bone Biopsy System: https://www.bd.com/en-us/products-and-solutions/products/product-families/bd-trek-powered-bone-biopsy-system Jamshidi Evolve Bone Marrow Needle: https://www.bd.com/en-us/products-and-solutions/products/product-families/jamshidi-evolve-bone-marrow-needle BD Illinois Sternal/Iliac Bone Marrow Aspiration Needles: https://www.bd.com/en-ca/products-and-solutions/products/product-families/illinois-sternal-iliac-bone-marrow-aspiration-needles BD Mission Disposable Core Biopsy Instrument: https://www.bd.com/en-us/products-and-solutions/products/product-families/mission-disposable-core-biopsy-instrument Disc Biopsy Visualization Website: https://www.pediatricir.com/disc-aspiration-for-discitis.html

Debuto ayer Yoshinobu Yamamoto. Llegara a ser una estrella en Grandes Ligas? Los Gigantes de San Francisco van por Blake Snell y Matt Chapman. Tenemos una actualizacion sobre Julio Rodriguez (J-Rod) y Justin Verlander. Todo esto y mas, en nuestro episodio de hoy en Baseball News.

Starting with small practices of advocacy at a very young age, Breanna Medcalfe, 21, is setting out on a journey to educate others and be a young voice for people with disability. Already making waves in medical alum by being a Health Consumer Disability Representative Advocate we were very lucky to have this time with her before her stratospheric launch into high profile advocacy! Moving from New Zealand to Australia after having a misdiagnosis. Breanna speaks to the support she's been shown here in Australia including accessible events, horseback riding and mentoring from a previous ListenABLE favourite Dinesh Palipana. This episode also discusses the importance of a good support worker who in this case is happy to work the night shift in exchange for a good dance floor boogie. Chair users also stick around as Breanna has a trick to keep track of where your friends are when out on the town, and it's more simple then sending a text.  Watch this episode on our YouTube with captions: https://youtu.be/7fZwwK35gC8 Connect With Breanna on LinkedIn Here: https://www.linkedin.com/in/breanna-medcalfe-0975b3209 Instagram here: https://www.instagram.com/breanna_medcalfe_advocate/ Join the 10,000+ legends on Instagram: @ListenABLE_ Podcast https://www.instagram.com/listenable_podcast/ Grab our first merch release at our website From Your Pocket https://fromyourpocket.com.au/work/listenable/merch Recorded, edited and produced by Angus' Podcast Company https://fromyourpocket.com.au/See omnystudio.com/listener for privacy information.

In this episode Dr. Michael Lenz  explores the historical understanding of chronic pain that lacks visible physical symptoms. He discusses stigma against sufferers, hypochondria, historical sex bias in pain understanding, and the transition in recognizing non-visible pain as real with the advent of functional MRIs. Dr. Lenz makes a case for the necessity of understanding the complexity of pain beyond the classic biomedical model and acknowledging the historical roots of current attitudes towards pain for better pain management in the present .00:00 Introduction to Chronic Pain and Stigma01:06 Understanding the Host's Background01:58 Exploring the Concept of Pain02:41 The Historical Perspective of Pain03:49 The Concept of Mechanical Objectivity05:19 The Clinical Gaze and its Impact08:56 The Role of Medical History in Understanding Pain09:17 The Stigma and Misunderstanding of Chronic Pain09:33 The Problem of Pain Without Lesion10:33 The Role of Forensic Science in Understanding Pain11:36 The Impact of Sex and Social Status on Pain Perception15:06 The Impact of Stigma on Pain Perception15:49 The Role of Modern Medical Approaches in Understanding Pain20:39 The Role of Legal Cases in Understanding Pain27:31 Conclusion: The Historical Impact on Current Pain Perception29:07 Final Thoughts  Support the showA Fibromyalgia Starter Pack, which is a great companion to the book Conquering Your Fibromyalgia, is now available. Dr. Michael Lenz practices general pediatrics and internal medicine primary care, seeing patients from infants through adults. In addition, he also will see patients with fibromyalgia and related problems and patients interested in lifestyle medicine and clinical lipidology. To learn more, go to ConquringYourFibromyalgia.com. Remember that while Dr. Lenz is a medical doctor, he is not your doctor. All of your signs and symptoms should be discussed with your own physician. He aims to weave the best of conventional medicine with lifestyle medicine to help people with chronic health conditions live their best lives possible. Dr. Lenz hopes that the podcast, book, blog, and website serve as a trusted resource and starting point on your journey of learning to live better with fibromyalgia and related illnesses.

HOW TO DEAL WITH AN INJURY? #motivation #keeprunning #runner #runeveryday #letsgetrunning HERE WE DISCUSS SOME STRATEGIES TO DEAL MENTALLY WITH AN INJURY. #run #runner #dreambig #running #runningreels #dontgetdistracted #runninggoals #runnergoals #grind #marathontraining #marathoner #halfmarathontraining #stayfocused #couchtohalfmarathon #runcoaching #couchto5k #reachgoals #runwithme #runnerscommunity #sub3 #elpepeavilesrun #runcoach #letmecoachyou #runrunrun #dontlimityourself #runshots MIS REDES SOCIALES: Facebook: @elpepeaviles Instagram:@elpepeaviles Tiktok: @elpepeaviles Rumble: https://rumble.com/c/c-1307472 En las plataformas de PODCAST: Tira y Jala Podcast https://open.spotify.com/show/6tmEezyJLVopiFnXrspylY https://anchor.fm/tirayjalapodcast --- Send in a voice message: https://podcasters.spotify.com/pod/show/tirayjalapodcast/message

Ultimo episodio de la temporada

Episode: 1095 The lesion within: Medicine learns look inside the human body.  Today, we try to locate the seat of disease.

Sabes la direrencia de un caso de Compensación al trabajador a un caso de demanda por lesion personal? Aquí en ponte al día te aclaramos tus dudas.

NXT REVIEW 12/19/2023 llija DRAGUNOV SUFRE GRAVE LESION!!! --- Send in a voice message: https://podcasters.spotify.com/pod/show/100xcientopodcast/message

In this episode, we review the high-yield topic of ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Motor Neuron Lesion Signs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠from the Neurology section. Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbull --- Send in a voice message: https://podcasters.spotify.com/pod/show/medbulletsstep1/message

The World Health Organization estimates 3.7 billion people under age 50 (67%) globally have herpes simplex virus type 1 (HSV-1) infection, the main cause of oral herpes, and 491 million people aged 15–49 (13%) worldwide have a herpes simplex virus type 2 (HSV-2) infection, the main cause of genital herpes.  Although treatable, most HSV infections are often asymptomatic or unrecognized.  Moreover, management of HSV infections is complicated by overlapping clinical presentation of unrelated herpesvirus infections, such as varicella-zoster virus (VZV), requiring differential diagnosis.  Innovations in molecular diagnostics continue to play a critical role in the diagnosis and management of these diseases.   About Our Speaker:    Lori Henderson earned a bachelor's degree in biology from Bucknell University. She began her career in the laboratory working on drug discovery and then transitioned into commercial roles within the biopharma and diagnostics sectors of the life science industry. Lori has direct experience in multiple disease and therapeutic areas and currently focuses on sexually transmitted diseases and women's health. Within the molecular business unit at QuidelOrtho, Lori is responsible for identifying and helping drive the development of products to meet clinical and patient needs.

In today's episode I...-Talk about what a SLAP lesion is-Review the most commonly used special tests-Throw in a few additional pearls to help better target SLAP lesions and so much more!Link to Physical Examination Maneuvers for SLAP LesionsO'Brien Test VideoSupport OEP today!Welcome to our new sponsor!  Chattanooga.  To check out all they have to offer, trial modalities, have your questions answered about shockwave therapy, high level laser, radial pressure wave, connect with them HERE!Want to join the OEP community? Click HERE to jump onto our email list. SUBSCRIBE at the bottom of the page.Ask me your ortho evaluation questions and I will answer them on the show: paul@orthoevalpal.comCome visit our WEBSITE!! Click HERE to check it outGet our downloadable 1.5 hour shoulder anatomy with cadaver dissection lectureGet our downloadable 7.5 hour cervical and lumbar continuing ed courseGet our downloadable 6.0 hour shoulder continuing ed courseBe sure to "follow" us on our new Facebook PageI finally made it to Instagram. Stop by and check us outAre you looking for One on one Coaching? We have it!Be sure to check out our 500+ videos on our YouTube Channel called Ortho Eval Pal with Paul Marquis#SLAP #shoulderpain #labraltear #o'brientest #podcastsforpt #PTpodcast #medical #health #orthopedics #Physicaltherapy #DPT #Medicalproviders #sportsmedicine #athletictraining #chiropractic #occupationaltherapySupport the show Thanks for listening! If you like our podcast, be sure to check out more of our great content at OrthoEvalPal.com, Instagram and Youtube. We'd love a rating or review on your podcast platform. And, as always, be kind to each other and take care!!

In this conversation with Dr. Vanessa Milanese, we cover the importance of anatomy in neurosurgery and explore her intriguing work in both fields – and how they cross-informed one another. Vanessa is a functional neurosurgeon at A Beneficencia Portuguesa Hospital in São Paulo, Brazil and holds an adjunct assistant professorship of neurosurgery at Mayo Clinic in Jacksonville, Florida. We talk about her stellar work in combining her neurosurgical activity with anatomical work – which involves dissections of the white matter of postmortem brains using the Klingler's method. We will talk about the rare community of neurosurgeons involved in similar activities, world-wide and the big influence Dr. Al Rhoton had on the field and on Vanessa's career. We thoroughly enjoyed this conversation and learned a lot – and we hope you will enjoy it as much as we did! Thank you so much for tuning in! References we talked about in the episode: Holanda, Vanessa M., Michael S. Okun, Erik H. Middlebrooks, Abuzer Gungor, Margaret E. Barry, John Forder, and Kelly D. Foote. 2020. “Postmortem Dissections of Common Targets for Lesion and Deep Brain Stimulation Surgeries.” Neurosurgery 86 (6): 860–72.  https://journals.lww.com/neurosurgery/abstract/2020/06000/postmortem_dissections_of_common_targets_for.14.aspx Holanda, Vanessa Milanesi, Maria Cristina Chavantes, Xingjia Wu, and Juanita J. Anders. 2017. “The Mechanistic Basis for Photobiomodulation Therapy of Neuropathic Pain by near Infrared Laser Light.” Lasers in Surgery and Medicine 49 (5): 516–24.  https://www.thieme-connect.de/products/ejournals/pdf/10.1002/lsm.22628.pdf Middlebrooks, Erik H., Ibrahim S. Tuna, Leonardo Almeida, Sanjeet S. Grewal, Joshua Wong, Michael G. Heckman, Elizabeth R. Lesser, et al. 2018. “Structural Connectivity-Based Segmentation of the Thalamus and Prediction of Tremor Improvement Following Thalamic Deep Brain Stimulation of the Ventral Intermediate Nucleus.” NeuroImage. Clinical 20 (October): 1266–73. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308387/ Middlebrooks, Erik H., Sanjeet S. Grewal, and Vanessa M. Holanda. 2019. “Complexities of Connectivity-Based DBS Targeting: Rebirth of the Debate on Thalamic and Subthalamic Treatment of Tremor.” NeuroImage. Clinical. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543122/ Ferreira, Tancredo Alcântara, Jr, Erik H. Middlebrooks, Wen Hung Tzu, Mateus Reghin Neto, and Vanessa Milanesi Holanda. 2020. “Postmortem Dissections of the Papez Circuit and Nonmotor Targets for Functional Neurosurgery.” World Neurosurgery 144 (December): e866–75. https://www.sciencedirect.com/science/article/abs/pii/S1878875020320969?via%3Dihub Additional Resources we talked about: Mayo Functional Neuro Course 2024:  https://ce.mayo.edu/functionalneuro2024 Scaniverse app for 3D brain reconstruction: https://apps.apple.com/br/app/scaniverse-3d-scanner/id1541433223?l=en-GB Rhoton's book: https://shop.lww.com/Rhoton-Cranial-Anatomy-and-Surgical-Approaches/p/9781975226879 Stênio Holanda Filho Q&A book: https://www.dilivros.com.br/livro-neuroanatomia-pratica-e-ilustrada-questoes--e-respostas--3d-9788580531527,h18213.html Deep Brain Stimulation: A case-based approach https://academic.oup.com/book/29505

Full article: https://www.ajronline.org/doi/10.2214/AJR.23.29670  Sid Dogra, MD discusses an AJR article in which the authors show that retained biopsy site markers following resection of breast lesions increases risk of residual malignancy, particularly in patients whose initial pathology suggested malignancy. Radiologists can improve patient care by more explicitly noting missing biopsy site markers and recommending early postoperative mammogram on initial intraoperative specimen radiographs.

En este episodio de Sports R Us Podcast nos ponemos al dia con el baseball de la MLB. Entre los temas discutidos, hablamos de:⚾️ Lesion de Shohei Ohtani y como esto afecta su agencia libre⚾️ Ronald Acuña se convierte en el 5to jugador en llegar al club de 40/40⚾️ Hablamos de los equipos que ya poncharon sus boletos a la post temporadaRecuerden que nos pueden seguir en:Facebookhttps://www.facebook.com/sportsruspodcast?mibextid=LQQJ4dInstagram https://instagram.com/sportsruspod?igshid=YWJhMjlhZTc=Youtube https://youtube.com/@sportruspodcastTikTokhttps://www.tiktok.com/@sportsruspodcast

Dr. Jason Crowell talks with Dr. Frederic Schaper about legion-related epilepsy mapping to a specific brain network.  Show references: https://jamanetwork.com/journals/jamaneurology/fullarticle/2806404 Full podcast: https://directory.libsyn.com/episode/index/id/27809031

Dr. Jason Crowell talks with Dr. Frederic Schaper about legion-related epilepsy mapping to specific brain networks.  Read the related article in JAMA Neurology.  Visit NPUb.org/Podcast for additional podcasts and associated article links.

Episode SummaryIn this episode of the Indiana Pioneer Agronomy podcast, hosts Carl Joern and Brian Shrader discuss Indiana crop outlook for corn and soybeans, planning for post-harvest and interesting pests and diseases they've encountered in the field. Soybean stem cankers, gray leaf spot and hover fly larvae have been spotted in a few fields throughout Indiana. A peculiar pest popped up in one field which was later identified as Disease Lesion Mimic Mutants. What are these mutants? Listen to find out!ResourcesCrop Focus Stem Canker: https://www.pioneer.com/us/agronomy/stem_canker_cropfocus2.htmlGray Leaf Spot: https://www.pioneer.com/us/agronomy/gray_leaf_spot_cropfocus.htmlCrop Focus Managing Gray Leaf Spot: https://www.pioneer.com/CMRoot/Pioneer/US/Non_Searchable/agronomy/cropfocus_pdf/gls_foliar_fungicide_cropfocus.pdfBeneficial Predators, Hover Flies: https://www.pioneer.com/CMRoot/international/hawaii/News/Pioneer_BeneficialInsects_Chart.pdfDisease Lesion Mimic Mutants: https://www.pioneer.com/us/agronomy/disease-lesion-mimic-mutants.html

 Dr. Linda Chu discusses the past, present, and future of adnexal lesion imaging with Dr. Elizabeth Sadowski.    Adnexal Lesion Imaging: Past, Present, and Future. Sadowski et al. Radiology 2023; 307(5):e 223281

August 11, 2023 Ray, Mark, and Scott discuss 2 questions that came into the Urology Coding and Reimbursement Group (see below for a link to sign up free):Good Evening Our office is looking into Chronic Care Management. We know that CCM requires the patient to have 2 chronic conditions. Most of these patients have prostate cancer and diabetes, and or hypertension. Which brings me to my question our providers will be treating and managing the cancer but as for as the diabetes goes they are not treating this or managing it in any way. Would we still be able to use this in out CCM billing?Hi, What CPT code set would you bill for Excision Scrotal Lesion(s)? (Path Report: Benign). Would you code with 11420-11426 or 11106-11107 or 54060 or something else? NOTE DETAILS: FINDING(s): Numerous scattered superficial skin lesions, In total 20cm skin removed. "We began by marking out the areas of concern with elliptical incisions. There were numerous lesions but they were spread out enough that we decided to do multiple separate incisions. After the lesions were marked the skin was anesthetized with 0.5% Macaine. Incisions were made sharply along the previous marked ellipse. The skin was then carefully dissected sharply from of the underlying dartos tissue. Hemostasis was achieved with bipolar cautery. This was repeated for all lesions."Urology Documentation, Coding, and Billing CertificationFor Urologists and APPs (Click Here for Pricing, More Information, and Registration)Documentation, Coding, and Billing Fellowship - Urology (DCB-FS) For Coders, Billers, and Admins (Click Here for Pricing, More Information, and Registration)Documentation, Coding, and Billing Specialist Certification (DCB-SC)Documentation, Coding, and Billing Master Certification (DCB-MC)Urology Advanced Coding and Reimbursement SeminarClick Here to Register Now  Las Vegas, December 1 & 2, 20238 am - 4:30 pm Friday, 8 am - 3:30 pm SaturdayNew Orleans, January 26 & 27, 20248 am - 4:30 pm Friday, 8 am - 3:30 pm SaturdayReserve your spot and save!As a Urology Coding and Reimbursement Podcast listener, you get access to a discount (limited-time offer).Use code: 24UACRS733Get signed up today and get peace of mind knowing you will be prepared for all the upcoming changes.The Thriving Urology Practice Facebook group.The Thriving Urology Practice Facebook Group link to join:https://www.facebook.com/groups/ThrivingPractice/ Join the discussion:Urology Coding and Reimbursement Group - Join for free and ask your questions, and share your wisdom.Click Here to Start Your Free Trial of AUACodingToday.com 

Skin and soft tissue infections are commonly induced by pressure and friction, causing disruption of the epidermal layer and microbial access to more vulnerable deeper tissue. This week's episode explores the possibility of such an infection in a 17-year-old transgender patient affirming as male in the setting of chest binding. With adolescent medicine specialist Dr. Katy Miller as well as show host Dr. Angela Kade Goepford, gender affirming care as well as assessing chronic pain in teenagers with mental health histories are explored as larger themes.

This Week on The Show: Parental Mental Health NightWith Kate Mulligan returning to give us an update about where she's been, and what she's been up to, The Parent's Lounge roars into the parenting station this week with a whole new crop of parenting talk.   Jamie updates everyone about the incident this week where the front of his car gets stolen.  Jason talks about updates on his twin's progressions with speech.  Jamie introduces a story from China, where kids are becoming "profesional children" to their parents, as parents are paying them to stay at home and be their children.  All these crazy topics, and so much more on this week's The Parent's Lounge.You can catch The Parent's Lounge live every Tuesday Night at 10pm EST/7pm PST at:https://www.facebook.com/theparentslounge#theparentslounge #stolencar #speechdelay #midlifecrisis #parentingpodcast #jamiekaler #jasongowin #katemulligan #comedians #parentingadvice #funnyparents #hilarious #cohosts #professionalchilren #NonVerbalChildren #Resourcesforspecialneedschildren #Impressions #standupcomedy #parenthoodJamie Kaler's Instagram - https://www.instagram.com/jamiekaler/Jason Gowin's Instagram - https://www.instagram.com/jasongowin/Kate Mulligan's Instagram - https://www.instagram.com/katestmomever/The Parent's Lounge TikTok - https://www.tiktok.com/@theparentsloungeshow

07/24/2023 | CT of Serous Cystadenomas of the Pancreas: A Lesion of Many Different Appearances - Part 3

07/17/2023 | CT of Serous Cystadenomas of the Pancreas: A Lesion of Many Different Appearances - Part 2

07/10/2023 | CT of Serous Cystadenomas of the Pancreas: A Lesion of Many Different Appearances - Part 1

In this episode, we review the high-yield topic of SLAP Lesion⁠⁠ ⁠⁠⁠⁠from the Shoulder & Elbow section. Follow ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Orthobullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on Social Media: Facebook: www.facebook.com/orthobullets Instagram: www.instagram.com/orthobulletsofficial Twitter: www.twitter.com/orthobullets LinkedIn: www.linkedin.com/company/27125689 YouTube: www.youtube.com/channel/UCMZSlD9OhkFG2t25oM14FvQ --- Send in a voice message: https://podcasters.spotify.com/pod/show/orthobullets/message

In the cardiac lesion series, Dr. Laura Ortmann, Pediatric Intensivist at Children's Hospital and Medical Center, discusses Interrupted Aortic Arch and the Yasui Procedure. Listen in to learn more! If you plan to listen to the cardiac lesion series in order, this episode follows the Reverse Potts Shunt. #drortmanncicu #picu #cicu #pediatrics